Follistim AQ (follitropin beta)

Controlled ovarian stimulation for IVF

Updated weekly · checked 3 h ago

A drug-price guide lists $213.11 per 75 IU at an ordinary retail pharmacy.

Cost

What Follistim costs, by pharmacy

Every cash price we found posted by a pharmacy, TrumpRx.gov or the manufacturer, read on the seller's own page on Oct 4, 2026, compared per one unit and cheapest first. A retail drug-price guide's figure is shown for context.

Where, and the product as listedPer 75 IU

Drugs.com price guideRetail price guide
Follistim AQ cartridge, 900 IU: from $2,557.35 for 1.08 milliliters
$213.11
read Oct 4, 2026
Drugs.com price guideRetail price guide
Follistim AQ cartridge, 300 IU: from $857.72 for 0.36 milliliters
$214.43
read Oct 4, 2026

Cash prices only: with insurance that covers fertility drugs you pay your plan's share instead, and most manufacturer programs cannot be combined with insurance. Prices change; each row links to the page it was read on. Compare every IVF medication, or see what a whole cycle's drugs cost after TrumpRx.

Savings

Programs that lower the cost of Follistim

Each program's own terms, read on its page. Eligibility is the program's to decide.

ReUnite RxOrganon, run by ReUnite Rx
Reduced everyday cash prices on Follistim AQ, Organon's ganirelix and Pregnyl at ReUnite network pharmacies. The prices are not published: the pharmacy quotes them.
Who qualifies: Patients not using insurance for their fertility medications.
How to enroll: No application or card: a ReUnite network pharmacy enrolls you when it fills the prescription. 844-385-5403.
Read Oct 4, 2026
ReUnite AssistOrganon, run by ReUnite Rx
A need-based discount on Follistim AQ, set after you apply. It lasts a year and cannot be combined with other programs.
Who qualifies: Prescriptions paid 100% in cash, with proof of income (Form 1040) for the household.
How to enroll: Apply online through the ReUnite Rx portal with proof of income.
Read Oct 4, 2026
ReUnite OncofertilityOrganon, run by ReUnite Rx
Up to 100% off the patient's cost, based on clinical and financial need, up to 2,700 IU of Follistim AQ, 5 ganirelix syringes and one 10,000 IU vial of Pregnyl.
Who qualifies: Women who need cancer treatment that affects fertility, with no prior chemotherapy, paying for fertility drugs themselves, with proof of income and a form from the oncologist.
How to enroll: Apply online through the ReUnite Rx portal with the oncologist form.
Read Oct 4, 2026

What pharmacies pay

The national acquisition cost (CMS NADAC)

The national average price a US retail pharmacy pays to acquire each product, published weekly by CMS. A wholesale floor, not the price you are charged.

No CMS acquisition cost for this medication

CMS surveys what retail pharmacies pay, and this medication is filled almost entirely by specialty pharmacies, so NADAC has no row for it. No figure is shown rather than an estimate.

Across a whole stimulation cycle, all the medications together typically total $3,000–$7,000, which is the number that matters for a budget. See the full cycle breakdown or how families pay for it.

In a cycle

When it is given

Daily subcutaneous injections through the stimulation phase of an IVF or egg-freezing cycle, with the dose adjusted at each monitoring scan and blood draw based on how the ovaries respond.

FDA label

What the prescribing information says

The current FDA structured product label, as published through openFDA and DailyMed. Excerpted verbatim, not summarised.

What the FDA label approves it for

1 INDICATIONS AND USAGE FOLLISTIM ® AQ Cartridge (follitropin beta) injection, is indicated: In Women for: FOLLISTIM AQ Cartridge is a gonadotropin indicated: In Women for: Induction of Ovulation and Pregnancy in Anovulatory Infertile Women in Whom the Cause of Infertility is Functional and Not Due to Primary Ovarian Failure ( 1.1 ) Pregnancy in Normal Ovulatory Women Undergoing Controlled Ovarian Stimulation as Part of an In Vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI) Cycle ( 1.2 ) In Men for: Induction of Spermatogenesis in Men with Primary and Secondary Hypogonadotropic Hypogonadism (HH) in Whom the Cause of Infertility is Not Due to Primary Testicular Failure ( 1.3 ) 1.1 Induction of Ovulation and Pregnancy in Anovulatory Infertile Women in Whom the Cause of Infertility is Functional and Not Due to Primary Ovarian Failure Prior to initiation of treatment with FOLLISTIM AQ Cartridge: Women should have a complete gynecologic and endocrinologic evaluation. Primary ovarian failure should be excluded. The possibility of pregnancy should be excluded. Tubal patency should be demonstrated. The fertility status of the male partner should be evaluated. 1.2 Pregna

Dosage and administration

2 DOSAGE AND ADMINISTRATION See Dose Conversion Table 1 for FOLLISTIM AQ Cartridge with Pen Injector ( 2.1 ) In Anovulatory Women Undergoing Ovulation Induction ( 2.2 ): Starting daily dose of 50 international units of FOLLISTIM AQ Cartridge is administered subcutaneously for at least the first 7 days. The dose is increased by 25 or 50 international units at weekly intervals until follicular growth and/or serum estradiol levels indicate an adequate response. When an acceptable pre-ovulatory state is achieved, final oocyte maturation is achieved with 5,000 to 10,000 international units of urinary human chorionic gonadotropin (hCG). The woman and her partner should have intercourse daily, beginning on the day prior to the administration of hCG and until ovulation becomes apparent. In Normal Ovulatory Women Undergoing Controlled Ovarian Stimulation as Part of an In Vitro Fertilization or Intracytoplasmic Sperm Injection Cycle ( 2.3 ): Starting dose of 200 international units (actual cartridge doses) of FOLLISTIM AQ Cartridge is administered subcutaneously for at least the first 7 days of treatment. Subsequent doses can be adjusted down or up based upon ovarian response as determined b

Warnings and cautions

5 WARNINGS AND PRECAUTIONS FOLLISTIM AQ Cartridge should be used only by physicians who are experienced in infertility treatment. FOLLISTIM AQ Cartridge contains a potent gonadotropic substance capable of causing Ovarian Hyperstimulation Syndrome (OHSS) [see Warnings and Precautions (5.2) ] with or without pulmonary or vascular complications [see Warnings and Precautions (5.3) ] and multiple births [see Warnings and Precautions (5.5) ] . Gonadotropin therapy requires the availability of appropriate monitoring facilities [see Warnings and Precautions (5.10) ] . Careful attention should be given to the diagnosis of infertility and in the selection of candidates for FOLLISTIM AQ Cartridge therapy [see Indications and Usage (1.1 , 1.2 , 1.3) and Dosage and Administration (2.2 , 2.3 , 2.4) ] . Switching to FOLLISTIM AQ Cartridge from other brands (manufacturer), types (recombinant, urinary), and/or methods of administration (FOLLISTIM Pen, conventional syringe) may necessitate an adjustment of the dose [see Dosage and Administration (2) ] . Treatment with FOLLISTIM AQ may result in: Abnormal Ovarian Enlargement ( 5.1 ) Ovarian Hyperstimulation Syndrome (OHSS) ( 5.2 ) Pulmonary and Vascu

Contraindications

4 CONTRAINDICATIONS FOLLISTIM AQ Cartridge is contraindicated in women and men who exhibit: Prior hypersensitivity to recombinant hFSH products or any component of FOLLISTIM AQ Cartridge. Reactions including anaphylaxis have been reported [see Adverse Reactions (6.2) ] High levels of FSH indicating primary gonadal failure Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders) [see Indications and Usage (1.1 , 1.2 , 1.3) ] Hypersensitivity reactions to streptomycin or neomycin. FOLLISTIM AQ may contain traces of these antibiotics Tumors of the ovary, breast, uterus, testis, hypothalamus or pituitary gland FOLLISTIM AQ Cartridge is also contraindicated in women who exhibit: Pregnancy [see Use in Specific Populations (8.1) ] Heavy or irregular vaginal bleeding of undetermined origin Ovarian cysts or enlargement not due to polycystic ovary syndrome (PCOS) Women and men who exhibit: Prior hypersensitivity to recombinant hFSH products ( 4 ) High levels of FSH indicating primary gonadal failure ( 4 ) Presence of uncontrolled non-gonadal endocrinopathies ( 4 ) Hypersensitivity reactions related to streptomycin or neomycin ( 4 ) Tumors of the

Label for Follistim AQ, source: openFDA structured product labels · as of Oct 4, 2026

Common questions

About Follistim

How much does Follistim cost?

A drug-price guide lists $213.11 per 75 IU at an ordinary retail pharmacy. Across a whole IVF cycle, all the medications together typically total $3,000 to $7,000.

Is there a savings program for Follistim?

Yes: ReUnite Rx (Organon, run by ReUnite Rx): Reduced everyday cash prices on Follistim AQ, Organon's ganirelix and Pregnyl at ReUnite network pharmacies. The prices are not published: the pharmacy quotes them. ReUnite Assist (Organon, run by ReUnite Rx): A need-based discount on Follistim AQ, set after you apply. It lasts a year and cannot be combined with other programs. ReUnite Oncofertility (Organon, run by ReUnite Rx): Up to 100% off the patient's cost, based on clinical and financial need, up to 2,700 IU of Follistim AQ, 5 ganirelix syringes and one 10,000 IU vial of Pregnyl. Each program states its own eligibility; read it on the program's page before you fill the prescription.

What is Follistim used for in fertility treatment?

Recombinant follicle-stimulating hormone (FSH) made by Organon, injected daily from a pen cartridge to grow multiple follicles. It does the same job as Gonal-f; which of the two a clinic prescribes is largely protocol, pharmacy and insurance preference. Daily subcutaneous injections through the stimulation phase of an IVF or egg-freezing cycle, with the dose adjusted at each monitoring scan and blood draw based on how the ovaries respond.

How is Follistim given?

Injectable. Daily subcutaneous injections through the stimulation phase of an IVF or egg-freezing cycle, with the dose adjusted at each monitoring scan and blood draw based on how the ovaries respond.

Other medications in a cycle

Posted cash prices are each seller's own published figure on the date shown; your price depends on the pharmacy, the quantity and your insurance. NADAC is the national average price a pharmacy pays to acquire a drug, not the price you are charged. Dosing here is quoted from the FDA label and is not a prescription: your protocol comes from your clinic. IVFcost.co is an informational data platform, not a medical provider, clinic, or laboratory. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Success rates depend heavily on individual circumstances and are not a promise of any outcome. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the clinic's own current figures.